BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33921216)

  • 1. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.
    Brehm TT; Pfefferle S; von Possel R; Kobbe R; Nörz D; Schmiedel S; Grundhoff A; Olearo F; Emmerich P; Robitaille A; Günther T; Braun P; Andersen G; Knobloch JK; Addo MM; Lohse AW; Aepfelbacher M; Fischer N; Schulze Zur Wiesch J; Lütgehetmann M
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response.
    Selhorst P; van Ierssel SH; Michiels J; Mariën J; Bartholomeeusen K; Dirinck E; Vandamme S; Jansens H; Ariën KK
    Clin Infect Dis; 2021 Nov; 73(9):e2985-e2991. PubMed ID: 33315049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    Rani PR; Imran M; Lakshmi JV; Jolly B; Jain A; Surekha A; Senthivel V; Chandrasekhar P; Divakar MK; Srinivasulu D; Bhoyar RC; Vanaja PR; Scaria V; Sivasubbu S
    J Med Virol; 2021 Jul; 93(7):4163-4165. PubMed ID: 33818797
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.
    Borgogna C; De Andrea M; Griffante G; Lai A; Bergna A; Galli M; Zehender G; Castello L; Ravanini P; Cattrini C; Mennitto A; Gennari A; Gariglio M
    J Med Virol; 2021 Dec; 93(12):6444-6446. PubMed ID: 34260066
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective immunity after recovery from SARS-CoV-2 infection.
    Kojima N; Klausner JD
    Lancet Infect Dis; 2022 Jan; 22(1):12-14. PubMed ID: 34762853
    [No Abstract]   [Full Text] [Related]  

  • 8. An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay.
    Ahsan H; Sonn JK; Lee YS; Islam SU; Khalil SK
    Viral Immunol; 2021 Nov; 34(9):588-596. PubMed ID: 34101517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
    Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
    Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The great escape? SARS-CoV-2 variants evading neutralizing responses.
    Prévost J; Finzi A
    Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
    Kim YI; Kim SM; Park SJ; Kim EH; Yu KM; Chang JH; Kim EJ; Casel MAB; Rollon R; Jang SG; Um J; Song MS; Jeong HW; Kim EG; Kim Y; Kim SY; Park JS; Park MS; Kwon GY; Yeo SG; Lee SA; Choi YJ; Jung JU; Choi YK
    Emerg Microbes Infect; 2021 Dec; 10(1):152-160. PubMed ID: 33407005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
    Klein J; Brito AF; Trubin P; Lu P; Wong P; Alpert T; Peña-Hernández MA; Haynes W; Kamath K; Liu F; Vogels CBF; Fauver JR; Lucas C; Oh J; Mao T; Silva J; Wyllie AL; Muenker MC; Casanovas-Massana A; Moore AJ; Petrone ME; Kalinich CC; Dela Cruz C; Farhadian S; Ring A; Shon J; Ko AI; Grubaugh ND; Israelow B; Iwasaki A; Azar MM;
    J Infect Dis; 2022 Feb; 225(3):374-384. PubMed ID: 34718647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
    Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT
    Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.
    Kim JM; Ryu B; Choe YJ; Jo HJ; Lee H; Kim HM; Lee NJ; Rhee JE; Chung YS; Han MG; Kim EJ; Park Y; Gwack J; Jin Y; Song J; Seo S; Gill B; Kim H; Park Y; Yoo CK; Jeong EK
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing.
    Loconsole D; Sallustio A; Accogli M; Centrone F; Casulli D; Madaro A; Tedeschi E; Parisi A; Chironna M
    Viruses; 2021 May; 13(5):. PubMed ID: 34066205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.
    Sanaie S; Golipour E; Shamekh A; Sadaie MR; Mahmoodpoor A; Yousefi M
    Int Immunopharmacol; 2021 Nov; 100():108108. PubMed ID: 34521025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.
    Marot S; Malet I; Leducq V; Zafilaza K; Sterlin D; Planas D; Gothland A; Jary A; Dorgham K; Bruel T; ; Burrel S; Boutolleau D; Schwartz O; Gorochov G; Calvez V; Marcelin AG
    Nat Commun; 2021 Feb; 12(1):844. PubMed ID: 33558507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.